Mesalamine Tablet, Delayed Release
Product Images NDC 62135-714

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 62135-714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bmesalamine Delayed-release Tablets, Usp 1.2g Ndc 62135-714-12 (120 Tablets label)

Mesalamine Delayed-Release Tablets, USP 1.2 g per tablet, oral administration, packaged by Chartwell RX, LLC. The label states once daily dosing and contains 120 tablets. It includes storage instructions and cautions such as keeping the medication out of children's reach and dispensing in a tight, light-resistant container. The label also features a barcode and states 'No Varnish'.*

FDA Label Image

Mesalamine Delayed-release Tablets, Usp 1.2g Ndc 62135-714-60 (60 Tablets label)

Mesalamine Delayed-Release Tablets, USP 1.2 g per tablet in a bottle label. The label shows the product is for oral use, prescription only, with 60 tablets per container. Manufactured by Chartwell RX, LLC, the label includes storage instructions and a barcode. The label emphasizes keeping medication out of reach of children and notes no varnish on the container.*

FDA Label Image

Image Description (Mesalamine Dr Tablets Structure)

Chemical structure of mesalamine, showing a benzene ring with amino (H2N), hydroxyl (OH), and carboxyl (COOH) functional groups attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.